|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-3-15
|
|
pubmed:abstractText |
In vivo biomarkers to predict progression of brain tumors are of great value in clinical practice. Therefore, the authors tested the hypothesis that changes in choline ratios by magnetic resonance (MR) spectroscopic imaging and/or relative tumor blood volume (rTBV) can differentiate clinically stable from progressive pediatric brain tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2004 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
100
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1246-56
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15022293-Adolescent,
pubmed-meshheading:15022293-Aspartic Acid,
pubmed-meshheading:15022293-Brain Chemistry,
pubmed-meshheading:15022293-Brain Neoplasms,
pubmed-meshheading:15022293-Child,
pubmed-meshheading:15022293-Child, Preschool,
pubmed-meshheading:15022293-Choline,
pubmed-meshheading:15022293-Disease Progression,
pubmed-meshheading:15022293-Female,
pubmed-meshheading:15022293-Humans,
pubmed-meshheading:15022293-Infant,
pubmed-meshheading:15022293-Magnetic Resonance Angiography,
pubmed-meshheading:15022293-Magnetic Resonance Spectroscopy,
pubmed-meshheading:15022293-Male,
pubmed-meshheading:15022293-Prognosis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.
|
|
pubmed:affiliation |
NMR Surgical Laboratory, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA. atzika@partners.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
